{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:46:31Z","timestamp":1784115991284,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Prior research suggests a potential link between ABO blood types and susceptibility to various malignancies. The correlation between ABO blood types and hematological myeloid neoplasms, however, remains inadequately explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study investigates the association between ABO blood groups and the incidence of hematological myeloid neoplasms in adolescents and adults.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective clinical study, 1,022 adolescent and adult cases of myeloid neoplasms diagnosed at our institution were initially considered. After excluding conditions potentially linked to ABO blood types from prior studies, 792 eligible cases were analyzed. These cases were categorized based on disease subtypes and compared with a control group for blood type distribution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings reveal a significantly higher prevalence of blood type A in patients with myeloid neoplasms compared to the control group, except for chronic myelocytic leukemia and myeloproliferative neoplasms. Conversely, the prevalence of blood type AB in myeloid neoplasms was notably lower than in the control group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The study suggests a potential association between ABO blood types and the risk of developing hematological myeloid neoplasms in adolescents and adults. Further research is warranted to elucidate the underlying mechanisms of this relationship.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1456695","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:26:23Z","timestamp":1726662383000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between ABO blood groups and hematological myeloid neoplasms in adolescents and adults"],"prefix":"10.3389","volume":"11","author":[{"given":"Miao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchuan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/345229a0","article-title":"Molecular genetic basis of the HISTO-blood group ABO system.","volume":"345","author":"Yamamoto","year":"1990","journal-title":"Nature."},{"key":"B2","first-page":"237","article-title":"Association of ABO and RH blood groups with type 2 diabetes mellitus.","volume":"20","author":"Meo","year":"2016","journal-title":"vEur Rev Med Pharmacol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.11909\/j.issn.1671-5411.2019.09.005","article-title":"Association of ABO blood groups with the severity of coronary artery disease: A cross-sectional study.","volume":"16","author":"Hong","year":"2019","journal-title":"J Geriatr Cardiol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.0.CO;2-0","article-title":"Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens.","volume":"73","author":"Zhang","year":"1997","journal-title":"Int J Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00277-004-0888-1","article-title":"Distribution of ABO blood groups in acute leukaemias and lymphomas.","volume":"83","author":"Vadivelu","year":"2004","journal-title":"Ann Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/08880010600907221","article-title":"Distribution of ABO blood groups in childhood acute leukemia.","volume":"23","author":"Alavi","year":"2006","journal-title":"Pediatr Hemat Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World health organization classification of myeloid neoplasms and acute leukemia.","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3748\/wjg.v18.i6.563","article-title":"ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.","volume":"18","author":"Gong","year":"2012","journal-title":"World J Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/ijc.26220","article-title":"ABO blood group and breast cancer incidence and survival.","volume":"130","author":"Gates","year":"2012","journal-title":"Int J Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ijc.28087","article-title":"ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China.","volume":"133","author":"Sheng","year":"2013","journal-title":"Int J Cancer."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/srep42925","article-title":"ABO blood types associated with the risk of venous thromboembolism in Han Chinese people: A hospital-based study of 200,000 patients.","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.numecd.2014.10.015","article-title":"ABO blood group in relation to plasma lipids and proprotein convertase subtilisin\/kexin type 9.","volume":"25","author":"Li","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ijid.2021.01.057","article-title":"ABO blood group as a risk factor for tuberculosis: A network meta-analysis.","volume":"104","author":"Chen","year":"2021","journal-title":"Int J Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2298","article-title":"ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta-analysis.","volume":"32","author":"Noori","year":"2022","journal-title":"Rev Med Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/jvh.12829","article-title":"Distribution of ABO\/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: A population-based cross-sectional study.","volume":"25","author":"Liu","year":"2018","journal-title":"J Viral Hepat."},{"key":"B16","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/1097-0142(19800415)45:8<2149::AID-CNCR2820450823>3.0.CO;2-7","article-title":"Expression of A and B tissue isoantigens in benign and malignant lesions of the breast.","volume":"45","author":"Strauchen","year":"1980","journal-title":"Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1210\/jc.2012-2781","article-title":"Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.","volume":"98","author":"Weisbrod","year":"2013","journal-title":"J Clin Endocr Metab."},{"key":"B18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/glycob\/cwf103","article-title":"Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells.","volume":"12","author":"Marionneau","year":"2002","journal-title":"Glycobiology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tmrv.2011.08.002","article-title":"ABO research in the modern era of genomics.","volume":"26","author":"Yamamoto","year":"2012","journal-title":"Transfus Med Rev."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004788","article-title":"DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients.","volume":"4","author":"Bianco-Miotto","year":"2009","journal-title":"PLoS One."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.3390\/ijms131013308","article-title":"ABO blood group system and gastric cancer: A case-control study and meta-analysis.","volume":"13","author":"Wang","year":"2012","journal-title":"Int J Mol Sci."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.100179","article-title":"Low frequency of blood group A in secondary central nervous system lymphoma.","volume":"3","author":"Abouzari","year":"2012","journal-title":"Surg Neurol Int."},{"key":"B23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11060-008-9516-6","article-title":"Low frequency of blood group A in primary central nervous system lymphoma.","volume":"87","author":"Gharouni","year":"2008","journal-title":"J Neuro Oncol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184295","article-title":"ABO blood type and the risk of cancer - findings from the Shanghai cohort study.","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.4103\/jfmpc.jfmpc_2167_21","article-title":"Clinical spectrum and treatment response in patient of chronic myeloid leukemia in correlation with ABO blood group.","volume":"11","author":"Meher","year":"2022","journal-title":"J Fam Med Prim Care."},{"key":"B26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/tmrv.2000.16228","article-title":"Blood groups and disease: A historical perspective.","volume":"14","author":"Garratty","year":"2000","journal-title":"Transfus Med Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ijc.28019","article-title":"Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.","volume":"133","author":"Rizzato","year":"2013","journal-title":"Int J Cancer."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1456695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:26:27Z","timestamp":1726662387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1456695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":27,"alternative-id":["10.3389\/fmed.2024.1456695"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1456695","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"article-number":"1456695"}}